Aeglea BioTherapeutics, Inc.’s $60 Million Common Stock And Pre-Funded Warrants Offering – Global Legal Chronicle Global Legal Chronicle
Davis Polk advised the joint book-running managers in connection with a $60 million SEC-registered common stock and pre-funded warrants offering by Aeglea …